Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 9:55 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Armistice Capital, LLC | 0 0.000% |
-2,742,000 (Position Closed) |
Filing History |
| 2022-02-11 7:47 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 0 0.000% |
-3,408,849 (Position Closed) |
Filing History |
| 2022-01-26 11:00 am Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 0 0.000% |
-1,487,800 (Position Closed) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
FMR CORP | 0 0.000% |
-4,575,536 (Position Closed) |
Filing History |
| 2021-10-20 3:42 pm Sale |
2021-10-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
HIRSCHMAN ORIN | 0 0.000% |
-1,611,313 (Position Closed) |
Filing History |
| 2021-10-19 4:26 pm Purchase |
2021-10-11 | 13D | Adamas Pharmaceuticals, Inc. ADMS |
Magnetar Financial LLC | 3,131,937 6.850% |
3,131,937 (New Position) |
Filing History |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
FMR CORP | 4,575,536 11.060% |
4,251,667 (+1312.77%) |
Filing History |
| 2021-03-01 6:06 pm Purchase |
2021-02-25 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 3,408,849 7.600% |
2,600,418 (+321.66%) |
Filing History |
| 2021-02-22 07:18 am Purchase |
2021-02-16 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
HIRSCHMAN ORIN | 1,611,313 11.000% |
1,611,313 (New Position) |
Filing History |
| 2021-02-16 2:47 pm Purchase |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Armistice Capital, LLC | 2,742,000 9.600% |
546,000 (+24.86%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 1,487,800 5.220% |
61,800 (+4.33%) |
Filing History |
| 2021-02-12 4:48 pm Sale |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 808,431 2.800% |
-1,432,808 (-63.93%) |
Filing History |
| 2021-02-12 08:23 am Sale |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Macquarie Group Limited | 0 0.000% |
-2,167,416 (Position Closed) |
Filing History |
| 2020-08-21 5:15 pm Purchase |
2020-08-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 1,426,000 5.040% |
1,426,000 (New Position) |
Filing History |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
BLACKROCK INC BLK |
598,070 2.100% |
-1,137,239 (-65.54%) |
Filing History |